CareDx Inc
NASDAQ:CDNA

Watchlist Manager
CareDx Inc Logo
CareDx Inc
NASDAQ:CDNA
Watchlist
Price: 22.68 USD 0.44% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
CareDx Inc?
Write Note

Intrinsic Value

The intrinsic value of one CDNA stock under the Base Case scenario is 16.9 USD. Compared to the current market price of 22.68 USD, CareDx Inc is Overvalued by 25%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CDNA Intrinsic Value
16.9 USD
Overvaluation 25%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
CareDx Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for CDNA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about CDNA?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about CareDx Inc

Provide an overview of the primary business activities
of CareDx Inc.

What unique competitive advantages
does CareDx Inc hold over its rivals?

What risks and challenges
does CareDx Inc face in the near future?

Has there been any significant insider trading activity
in CareDx Inc recently?

Summarize the latest earnings call
of CareDx Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for CareDx Inc.

Provide P/S
for CareDx Inc.

Provide P/E
for CareDx Inc.

Provide P/OCF
for CareDx Inc.

Provide P/FCFE
for CareDx Inc.

Provide P/B
for CareDx Inc.

Provide EV/S
for CareDx Inc.

Provide EV/GP
for CareDx Inc.

Provide EV/EBITDA
for CareDx Inc.

Provide EV/EBIT
for CareDx Inc.

Provide EV/OCF
for CareDx Inc.

Provide EV/FCFF
for CareDx Inc.

Provide EV/IC
for CareDx Inc.

Show me price targets
for CareDx Inc made by professional analysts.

What are the Revenue projections
for CareDx Inc?

How accurate were the past Revenue estimates
for CareDx Inc?

What are the Net Income projections
for CareDx Inc?

How accurate were the past Net Income estimates
for CareDx Inc?

What are the EPS projections
for CareDx Inc?

How accurate were the past EPS estimates
for CareDx Inc?

What are the EBIT projections
for CareDx Inc?

How accurate were the past EBIT estimates
for CareDx Inc?

Compare the revenue forecasts
for CareDx Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of CareDx Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of CareDx Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of CareDx Inc compared to its peers.

Compare the P/E ratios
of CareDx Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing CareDx Inc with its peers.

Analyze the financial leverage
of CareDx Inc compared to its main competitors.

Show all profitability ratios
for CareDx Inc.

Provide ROE
for CareDx Inc.

Provide ROA
for CareDx Inc.

Provide ROIC
for CareDx Inc.

Provide ROCE
for CareDx Inc.

Provide Gross Margin
for CareDx Inc.

Provide Operating Margin
for CareDx Inc.

Provide Net Margin
for CareDx Inc.

Provide FCF Margin
for CareDx Inc.

Show all solvency ratios
for CareDx Inc.

Provide D/E Ratio
for CareDx Inc.

Provide D/A Ratio
for CareDx Inc.

Provide Interest Coverage Ratio
for CareDx Inc.

Provide Altman Z-Score Ratio
for CareDx Inc.

Provide Quick Ratio
for CareDx Inc.

Provide Current Ratio
for CareDx Inc.

Provide Cash Ratio
for CareDx Inc.

What is the historical Revenue growth
over the last 5 years for CareDx Inc?

What is the historical Net Income growth
over the last 5 years for CareDx Inc?

What is the current Free Cash Flow
of CareDx Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for CareDx Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
CareDx Inc

Current Assets 334.1m
Cash & Short-Term Investments 240.9m
Receivables 66.6m
Other Current Assets 26.6m
Non-Current Assets 142.9m
PP&E 59.8m
Intangibles 80.7m
Other Non-Current Assets 2.4m
Current Liabilities 81.4m
Accounts Payable 6.2m
Accrued Liabilities 45.3m
Other Current Liabilities 29.9m
Non-Current Liabilities 122.3m
Other Non-Current Liabilities 122.3m
Efficiency

Earnings Waterfall
CareDx Inc

Revenue
312.8m USD
Cost of Revenue
-107.1m USD
Gross Profit
205.7m USD
Operating Expenses
-264m USD
Operating Income
-58.3m USD
Other Expenses
-85.2m USD
Net Income
-143.6m USD

Free Cash Flow Analysis
CareDx Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CDNA Profitability Score
Profitability Due Diligence

CareDx Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
Positive 1-Year Revenue Growth
21/100
Profitability
Score

CareDx Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

CDNA Solvency Score
Solvency Due Diligence

CareDx Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
High Altman Z-Score
69/100
Solvency
Score

CareDx Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CDNA Price Targets Summary
CareDx Inc

Wall Street analysts forecast CDNA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CDNA is 34.39 USD with a low forecast of 28.28 USD and a high forecast of 42 USD.

Lowest
Price Target
28.28 USD
25% Upside
Average
Price Target
34.39 USD
52% Upside
Highest
Price Target
42 USD
85% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CDNA?

Click here to dive deeper.

Dividends

CareDx Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CDNA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CDNA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

CDNA News

Other Videos

Profile

CareDx Inc Logo
CareDx Inc

Country

United States of America

Industry

Biotechnology

Market Cap

1.2B USD

Dividend Yield

0%

Description

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. The company is headquartered in South San Francisco, California and currently employs 633 full-time employees. The company went IPO on 2014-07-17. The firm is focused on the discovery, development, and commercialization of clinically differentiated, diagnostic solutions for transplant patients and caregivers. The firm offers testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. Its commercially available testing services consist of AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its suite of AlloSeq products include AlloSeq Tx, AlloSeq cfDNA, AlloSeq HCT, TruSight HLA, Olerup SSP and QTYPE. The company develops and provides diagnostic surveillance testing services for various transplant recipients.

Contact

CALIFORNIA
South San Francisco
1 Tower Place, 9Th Floor
+14152872300.0
www.caredx.com

IPO

2014-07-17

Employees

633

Officers

CFO & Principal Accounting Officer
Mr. Abhishek Jain
Executive Director
Dr. Peter Maag Ph.D.
President, CEO & Director
Mr. John Walter Hanna Jr.
Chief Operating Officer
Mr. Keith S. Kennedy C.F.A., CPA
Chief Scientific Officer
Dr. Robert N. Woodward Ph.D.
General Counsel & Secretary
Mr. Jeffrey A. Novack
Show More
Senior VP & Head of Human Resources
Ms. Stacey Follon
Head of Software Engineering
Mr. Kashif Rathore
Chief Strategy Officer
Ms. Marica Grskovic Ph.D.
Chief Commercial Officer
Ms. Jessica Meng
Show Less

See Also

Discover More
What is the Intrinsic Value of one CDNA stock?

The intrinsic value of one CDNA stock under the Base Case scenario is 16.9 USD.

Is CDNA stock undervalued or overvalued?

Compared to the current market price of 22.68 USD, CareDx Inc is Overvalued by 25%.

Back to Top